Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein-Reference-Cited by-同舟云学术

Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein

Published:2019-07 Issue: Volume:64 Page:194-201
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Goulding Susan R.,Sullivan Aideen M.,O'Keeffe Gerard W.^ORCID,Collins Louise M.^ORCID

Funder

RISAM scholarship from Cork Institute of Technology

Science Foundation Ireland

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference30 articles.

1. Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease;O'Keeffe;Park. Relat. Disord.,2018

2. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease;Kruger;Nat. Genet.,1998

3. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease;Polymeropoulos;Sci. (N. Y.),1997

4. alpha-Synuclein locus triplication causes Parkinson's disease;Singleton;Sci. (N. Y.),2003

5. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease;Chartier-Harlin;Lancet (London, England),2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human α‐synuclein overexpression upregulates SKOR1 in a rat model of simulated nigrostriatal ageing;Aging Cell;2024-03-26

2. Brain-Derived Neurotrophic Factor – The Protective Agent Against Neurological Disorders;CNS & Neurological Disorders - Drug Targets;2024-03

3. Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration;Frontiers in Molecular Neuroscience;2022-12-22

4. The promise of the TGF-β superfamily as a therapeutic target for Parkinson's disease;Neurobiology of Disease;2022-09

5. Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease;Neural Regeneration Research;2022